4.8 Article

SseL, a Salmonella deubiquitinase required for macrophage killing and virulence

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.0610095104

关键词

cytotoxicity; SPI-2; deubiquitinating enzyme

资金

  1. Medical Research Council [G9717183] Funding Source: Medline
  2. Wellcome Trust Funding Source: Medline
  3. Medical Research Council [G9717183] Funding Source: researchfish
  4. MRC [G9717183] Funding Source: UKRI

向作者/读者索取更多资源

Expression of the Salmonella enterica serovar Typhimurium pathogenicity island 2 (SPI-2) type III secretion system is controlled by the two-component regulatory system SsrA-SsrB. We used a transcriptomic approach to help define the SsrA-SsrB regulon. We identified a gene encoding an uncharacterized effector (SseL) whose translocation into host cells depends on the SPI-2 secretion system. SseL has similarities to cysteine proteases with deubiquitinating activity. A GST-SseL fusion protein specifically hydrolyzed mono- and polyubiquitin substrates in vitro with a preference for K63-linked ubiquitin chains. Ubiquitin-modified proteins accumulated in macrophages infected with Salmonella sseL mutant strains but to a lesser extent when infected with bacteria expressing active protein, demonstrating that SseL functions as a deubiquitinase in vivo. Salmonella sseL mutant strains did not show a replication defect or induce altered levels of cytokine production upon infection of macrophages but were defective for a delayed cytotoxic effect and were attenuated for virulence in mice.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据